What is Open Innovation in pharmaceutical R&D? 18/07/2024 Healthcare Access to innovation Drug discovery Innovative drugs The core idea of Open innovation is that companies leverage the ideas and resources of external actors such as customers... Partners - GENESIS Biomed
Integra Therapeutics to receive up to €10.5 million from European Commission for its FiCAT... 17/07/2024 Healthcare Access to innovation Rare diseases Advanced therapies EU projects This funding will enable Integra Therapeutics to launch its first gene therapy to treat a serious pediatric hepatic... Partners - Integra Therapeutics S.L.
It’s “All-go” with Oligos: Challenges and Opportunities in LC-MS of Therapeutic 17/07/2024 Healthcare Access to innovation The episode will focus on oligonucleotide LC-MS, covering key challenges, the critical importance of assay sensitivity... Partners
AseBio values the call for grants aimed at the development of UiC positively but regrets t... 16/07/2024 Healthcare Access to innovation Financing We trust that the call will strengthen the country's clinical research capabilities, which will help consolidate Spain's... AseBio
The Teófilo Hernando Foundation (FTH), CRO in Spain and Portugal, supports a clinical stud... 05/07/2024 Healthcare Access to innovation The participation of two of the participating sites in Spain, Hospital Universitario de Toledo and Hospital... Partners - Fundación Teófilo Hernando (FTH)
Almirall and the Centre for Genomic Regulation (CRG) Advance Research on Atopic Dermatitis 02/07/2024 Healthcare Access to innovation Rare diseases The research objectives of this collaboration include the characterization of experimental models of AD to identity... Partners - Almirall
Augustine Therapeutics raises EUR 17 million in a series a first closing to advance lead c... 01/07/2024 Healthcare Access to innovation Financing Proceeds will advance lead candidate AGT100216, a peripherally restricted and selective HDAC6 inhibitor, into a first-in... Partners - Asabys Partners
The European authority HERA visits HIPRA for its productive capacity in the face of future... 27/06/2024 Healthcare Access to innovation Drug discovery Industrial biotechnology The top leadership team from HERA (Health Emergency Preparedness and Response), the European Commission's authority for... Partners - HIPRA HUMAN HEALTH S.L.U.
Oryzon announces presentation of final data from PORTICO, vafidemstat’s global Phase IIb ... 26/06/2024 Healthcare Access to innovation Rare diseases Advanced therapies Seleccionada para presentación oral. La conferencia se celebrará en Milán del 21-23 de septiembre. Partners - Oryzon Genomics
AseBio and the Ministry of Health analyze the challenges and opportunities of Artificial I... 25/06/2024 Healthcare Access to innovation The event "Challenges and Opportunities for Spain in the Application of AI in Health Data Spaces," organized by AseBio... AseBio
